Lombardi Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia 20007-2197
0 studies enrolling now · 38 studies all time
What they study most
Anal Cancer, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Chronic Lymphocytic Leukemia, Colorectal Cancer, Endometrial Cancer, Extragonadal Germ Cell Tumor, Graft Versus Host Disease, Infection, Kidney Cancer, Leukemia
Studies at this site
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor — Completed
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
- Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer — Completed
- Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL) — Completed
- FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum — Stopped early
- Surgery in Treating Children With Neuroblastoma — Completed
- Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer — Stopped early
- Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer — Completed
- Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma — Completed
- Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma — Completed
- Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver — Completed
- Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer — Completed
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
- Combination Chemotherapy in Treating Patients With Bladder Cancer — Completed
- Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia — Completed
- Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma — Completed
- Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) — Completed
- Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors — Stopped early
- PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma — Completed
- Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer — Completed
- DNA Variations in the Gene in Young Patients With Wilms' Tumor — Completed
- Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer — Completed
- Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia — Completed
- Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
- Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia — Completed
- Combination Chemotherapy in Treating Children With Neuroblastoma — Completed
- Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma — Completed
- Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy — Completed
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma — Completed
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma — Completed
- Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease — Completed
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer — Completed
- Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma — Stopped early
- Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome — Completed
- Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer — Completed
- Anidulafungin in Treating Immunocompromised Children With Neutropenia — Completed
- S9630, Medroxyprogesterone in Treating Women With Breast Cancer — Completed
- Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer — Completed